Abnormal activation of the PI3K/AKT/mTOR signaling pathway has been found in a number of cancers affects nearly 50% of malignant tumors, including HCC, and mediates cancer cell proliferation, migration, invasion, angiogenesis and other pathological processes in tumor cells (18–20). This evidence concerns the gene AKT1 and hepatocellular carcinoma.